Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-03-02 @ 5:52 PM
Study NCT ID:
NCT01706250
Status:
COMPLETED
Last Update Posted:
2017-08-23
First Post:
2012-10-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™
Sponsor:
Stiefel, a GSK Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09-01
Start Date Type:
None
Primary Completion Date:
2010-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-11
First Submit QC Date:
None
Study First Post Date:
2012-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-04
Results First Submit QC Date:
None
Results First Post Date:
2017-06-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-19
Last Update Post Date:
2017-08-23
Last Update Post Date Type:
ACTUAL